Biopharmaceutical company Verastem Oncology has announced a new Phase 2 clinical trial for low-grade serous cancer (LGSOC). The trial will …
Covid, Cancer and Christmas
A Year of Change By Diane Evans-Wood Last year I wrote a blog about how to get through Christmas whilst …
Step Up for Ovarian Cancer UK
Virtual Edinburgh Kilt Walk 11th to 13th of September This September is Gynaecological Cancer Awareness Month. We’re asking you to …
Virtual Dundee Kiltwalk 2020
New Zealand women complete the Dundee Virtual Kilt Walk while UK sleeps While Scotland slept on Thursday night, two women …
UK Ovarian Cancer Awareness Month
March is Ovarian Cancer Awareness Month in the United Kingdom Every day twenty women are diagnosed will be diagnosed with …
Coping with cancer at Christmas
It’s November and already that time of year again when the Christmas adverts appear on TV and the shops are …
Binimetinib in low-grade serous carcinoma
A phase II study of Selumetinib, an oral small-molecule inhibitor of MEK1/2, has shown promising results in patients with recurrent …
Giving CuresDay on Giving Tuesday
Cure Our Ovarian Cancer is Celebrating Giving Tuesday in the UK with #GivingCuresDay joining millions around the world participating in …
Hospice Care Week
The 7th to 13th October 2019 is Hospice Care week in the UK. “Hospice Care Week is our chance to …
Study Shows Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial
Results from GOG 0281, a randomised phase II/III clinical trial, were presented by Dr Gershenson on Sunday at the European …